Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Hummingbird Bioscience is a clincal-stage biotechnology company. | ||||||
Lava Therapeutics is a biotechnology research company developing bispecific gamma-delta T cell engaging (bsTCE) antibodies to fight cancer. | ||||||
Eyevensys is a clinical stage, private, biotechnology company that was founded in 2008. | ||||||
Immuno-modulatory antibodies | ||||||
Memo Therapeutics is an antibody Discovery Technology founded in 2012. | ||||||
Vico Therapeutics is a medicine for rare neurological diseases founded in 2019. | ||||||
Araris Biotech is a fast/precise production of antibody-drug conjugates founded in 2019 by Philipp Spycher. | ||||||
Developer of monoclonal antibody for immune-mediated inflammatory diseases by targeting Neutrophil extracellular traps (NETs). | ||||||
Engimmune Therapeutics is a platform engineering next-generation T cell receptor therapies founded in 2021 by Søren Mouritsen. | ||||||
Ariceum Therapeutics is developing novel drugs for systemic targeted radiation therapy. | ||||||
Antibody drug conjugates (ADC) developer. | ||||||
Araris Biotech is a developer of an antibody-drug conjugates (ADCs founded in 2019. | ||||||
Corlieve Therapeutics is a biotechnology company. |